nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvoxamine—CYP1A2—Imiquimod—skin cancer	0.0769	0.103	CbGbCtD
Fluvoxamine—CYP1A1—Dacarbazine—skin cancer	0.0723	0.0965	CbGbCtD
Fluvoxamine—CYP2C19—Vismodegib—skin cancer	0.0577	0.0771	CbGbCtD
Fluvoxamine—CYP2E1—Dacarbazine—skin cancer	0.0558	0.0745	CbGbCtD
Fluvoxamine—CYP2C9—Vismodegib—skin cancer	0.048	0.0641	CbGbCtD
Fluvoxamine—ABCB1—Vismodegib—skin cancer	0.0466	0.0622	CbGbCtD
Fluvoxamine—CYP1A2—Vemurafenib—skin cancer	0.0421	0.0562	CbGbCtD
Fluvoxamine—CYP3A4—Imiquimod—skin cancer	0.0403	0.0538	CbGbCtD
Fluvoxamine—CYP3A4—Temozolomide—skin cancer	0.0403	0.0538	CbGbCtD
Fluvoxamine—CYP2D6—Vemurafenib—skin cancer	0.0347	0.0463	CbGbCtD
Fluvoxamine—CYP1A2—Dacarbazine—skin cancer	0.0323	0.0431	CbGbCtD
Fluvoxamine—CYP3A4—Vismodegib—skin cancer	0.0279	0.0373	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Docetaxel—skin cancer	0.0259	0.0346	CbGbCtD
Fluvoxamine—CYP3A7—Docetaxel—skin cancer	0.0259	0.0346	CbGbCtD
Fluvoxamine—ABCB1—Dactinomycin—skin cancer	0.0245	0.0327	CbGbCtD
Fluvoxamine—CYP3A4—Vemurafenib—skin cancer	0.0221	0.0295	CbGbCtD
Fluvoxamine—CYP3A5—Docetaxel—skin cancer	0.0194	0.0259	CbGbCtD
Fluvoxamine—CYP1A2—Fluorouracil—skin cancer	0.0189	0.0253	CbGbCtD
Fluvoxamine—CYP2C9—Fluorouracil—skin cancer	0.0171	0.0228	CbGbCtD
Fluvoxamine—ABCB1—Docetaxel—skin cancer	0.0126	0.0169	CbGbCtD
Fluvoxamine—CYP3A4—Docetaxel—skin cancer	0.00757	0.0101	CbGbCtD
Fluvoxamine—Ill-defined disorder—Dactinomycin—skin cancer	0.00022	0.000878	CcSEcCtD
Fluvoxamine—Anaemia—Dactinomycin—skin cancer	0.00022	0.000875	CcSEcCtD
Fluvoxamine—Liver function test abnormal—Docetaxel—skin cancer	0.000219	0.000873	CcSEcCtD
Fluvoxamine—Vomiting—Vemurafenib—skin cancer	0.000218	0.000869	CcSEcCtD
Fluvoxamine—Alopecia—Temozolomide—skin cancer	0.000218	0.000869	CcSEcCtD
Fluvoxamine—Dry skin—Docetaxel—skin cancer	0.000217	0.000866	CcSEcCtD
Fluvoxamine—Chest pain—Bleomycin—skin cancer	0.000217	0.000864	CcSEcCtD
Fluvoxamine—Myalgia—Bleomycin—skin cancer	0.000217	0.000864	CcSEcCtD
Fluvoxamine—Orthostatic hypotension—Docetaxel—skin cancer	0.000217	0.000863	CcSEcCtD
Fluvoxamine—Rash—Vemurafenib—skin cancer	0.000216	0.000862	CcSEcCtD
Fluvoxamine—Mental disorder—Temozolomide—skin cancer	0.000216	0.000861	CcSEcCtD
Fluvoxamine—Dermatitis—Vemurafenib—skin cancer	0.000216	0.000861	CcSEcCtD
Fluvoxamine—Hypersensitivity—Imiquimod—skin cancer	0.000216	0.000859	CcSEcCtD
Fluvoxamine—Headache—Vemurafenib—skin cancer	0.000215	0.000856	CcSEcCtD
Fluvoxamine—Malnutrition—Temozolomide—skin cancer	0.000215	0.000856	CcSEcCtD
Fluvoxamine—Breast disorder—Docetaxel—skin cancer	0.000214	0.000854	CcSEcCtD
Fluvoxamine—Discomfort—Bleomycin—skin cancer	0.000214	0.000854	CcSEcCtD
Fluvoxamine—Malaise—Dactinomycin—skin cancer	0.000214	0.000853	CcSEcCtD
Fluvoxamine—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000214	0.000851	CcSEcCtD
Fluvoxamine—Leukopenia—Dactinomycin—skin cancer	0.000213	0.000847	CcSEcCtD
Fluvoxamine—Dysgeusia—Temozolomide—skin cancer	0.00021	0.000838	CcSEcCtD
Fluvoxamine—Asthenia—Imiquimod—skin cancer	0.00021	0.000836	CcSEcCtD
Fluvoxamine—Confusional state—Bleomycin—skin cancer	0.00021	0.000835	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Bleomycin—skin cancer	0.000208	0.000828	CcSEcCtD
Fluvoxamine—Oedema—Bleomycin—skin cancer	0.000208	0.000828	CcSEcCtD
Fluvoxamine—Back pain—Temozolomide—skin cancer	0.000208	0.000828	CcSEcCtD
Fluvoxamine—Pruritus—Imiquimod—skin cancer	0.000207	0.000825	CcSEcCtD
Fluvoxamine—Infection—Bleomycin—skin cancer	0.000206	0.000823	CcSEcCtD
Fluvoxamine—Dysphagia—Docetaxel—skin cancer	0.000205	0.000817	CcSEcCtD
Fluvoxamine—Nausea—Vemurafenib—skin cancer	0.000204	0.000812	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Bleomycin—skin cancer	0.000203	0.000811	CcSEcCtD
Fluvoxamine—Arrhythmia—Fluorouracil—skin cancer	0.000203	0.000809	CcSEcCtD
Fluvoxamine—Vision blurred—Temozolomide—skin cancer	0.000202	0.000807	CcSEcCtD
Fluvoxamine—Myalgia—Dactinomycin—skin cancer	0.000202	0.000806	CcSEcCtD
Fluvoxamine—Tremor—Temozolomide—skin cancer	0.000201	0.000802	CcSEcCtD
Fluvoxamine—Alopecia—Fluorouracil—skin cancer	0.000201	0.000801	CcSEcCtD
Fluvoxamine—Diarrhoea—Imiquimod—skin cancer	0.0002	0.000798	CcSEcCtD
Fluvoxamine—Discomfort—Dactinomycin—skin cancer	0.0002	0.000796	CcSEcCtD
Fluvoxamine—Angina pectoris—Docetaxel—skin cancer	0.0002	0.000796	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Temozolomide—skin cancer	0.000199	0.000794	CcSEcCtD
Fluvoxamine—Anaemia—Temozolomide—skin cancer	0.000199	0.000791	CcSEcCtD
Fluvoxamine—Anorexia—Bleomycin—skin cancer	0.000198	0.000789	CcSEcCtD
Fluvoxamine—Agitation—Temozolomide—skin cancer	0.000197	0.000787	CcSEcCtD
Fluvoxamine—Angioedema—Temozolomide—skin cancer	0.000196	0.000782	CcSEcCtD
Fluvoxamine—Hypotension—Bleomycin—skin cancer	0.000194	0.000774	CcSEcCtD
Fluvoxamine—Oedema—Dactinomycin—skin cancer	0.000194	0.000772	CcSEcCtD
Fluvoxamine—Malaise—Temozolomide—skin cancer	0.000194	0.000772	CcSEcCtD
Fluvoxamine—Dizziness—Imiquimod—skin cancer	0.000193	0.000771	CcSEcCtD
Fluvoxamine—Vertigo—Temozolomide—skin cancer	0.000193	0.000769	CcSEcCtD
Fluvoxamine—Infection—Dactinomycin—skin cancer	0.000193	0.000767	CcSEcCtD
Fluvoxamine—Leukopenia—Temozolomide—skin cancer	0.000192	0.000766	CcSEcCtD
Fluvoxamine—Palpitations—Temozolomide—skin cancer	0.00019	0.000756	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Dactinomycin—skin cancer	0.00019	0.000756	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000189	0.000755	CcSEcCtD
Fluvoxamine—Cough—Temozolomide—skin cancer	0.000187	0.000747	CcSEcCtD
Fluvoxamine—Paraesthesia—Bleomycin—skin cancer	0.000187	0.000744	CcSEcCtD
Fluvoxamine—Weight increased—Docetaxel—skin cancer	0.000187	0.000743	CcSEcCtD
Fluvoxamine—Vision blurred—Fluorouracil—skin cancer	0.000187	0.000743	CcSEcCtD
Fluvoxamine—Convulsion—Temozolomide—skin cancer	0.000186	0.000742	CcSEcCtD
Fluvoxamine—Vomiting—Imiquimod—skin cancer	0.000186	0.000741	CcSEcCtD
Fluvoxamine—Weight decreased—Docetaxel—skin cancer	0.000185	0.000739	CcSEcCtD
Fluvoxamine—Hypertension—Temozolomide—skin cancer	0.000185	0.000739	CcSEcCtD
Fluvoxamine—Dyspnoea—Bleomycin—skin cancer	0.000185	0.000738	CcSEcCtD
Fluvoxamine—Anorexia—Dactinomycin—skin cancer	0.000185	0.000736	CcSEcCtD
Fluvoxamine—Rash—Imiquimod—skin cancer	0.000184	0.000735	CcSEcCtD
Fluvoxamine—Dermatitis—Imiquimod—skin cancer	0.000184	0.000734	CcSEcCtD
Fluvoxamine—Pneumonia—Docetaxel—skin cancer	0.000184	0.000733	CcSEcCtD
Fluvoxamine—Headache—Imiquimod—skin cancer	0.000183	0.00073	CcSEcCtD
Fluvoxamine—Anaemia—Fluorouracil—skin cancer	0.000183	0.000729	CcSEcCtD
Fluvoxamine—Arthralgia—Temozolomide—skin cancer	0.000183	0.000729	CcSEcCtD
Fluvoxamine—Myalgia—Temozolomide—skin cancer	0.000183	0.000729	CcSEcCtD
Fluvoxamine—Anxiety—Temozolomide—skin cancer	0.000182	0.000726	CcSEcCtD
Fluvoxamine—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000181	0.000722	CcSEcCtD
Fluvoxamine—Discomfort—Temozolomide—skin cancer	0.000181	0.00072	CcSEcCtD
Fluvoxamine—Decreased appetite—Bleomycin—skin cancer	0.000181	0.00072	CcSEcCtD
Fluvoxamine—Acute coronary syndrome—Docetaxel—skin cancer	0.00018	0.000718	CcSEcCtD
Fluvoxamine—Renal failure—Docetaxel—skin cancer	0.00018	0.000716	CcSEcCtD
Fluvoxamine—Myocardial infarction—Docetaxel—skin cancer	0.000179	0.000714	CcSEcCtD
Fluvoxamine—Neuropathy peripheral—Docetaxel—skin cancer	0.000179	0.000714	CcSEcCtD
Fluvoxamine—Dry mouth—Temozolomide—skin cancer	0.000179	0.000713	CcSEcCtD
Fluvoxamine—Stomatitis—Docetaxel—skin cancer	0.000178	0.00071	CcSEcCtD
Fluvoxamine—Jaundice—Docetaxel—skin cancer	0.000178	0.00071	CcSEcCtD
Fluvoxamine—Pain—Bleomycin—skin cancer	0.000178	0.000708	CcSEcCtD
Fluvoxamine—Conjunctivitis—Docetaxel—skin cancer	0.000178	0.000708	CcSEcCtD
Fluvoxamine—Leukopenia—Fluorouracil—skin cancer	0.000177	0.000706	CcSEcCtD
Fluvoxamine—Confusional state—Temozolomide—skin cancer	0.000177	0.000704	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000177	0.000704	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Temozolomide—skin cancer	0.000175	0.000699	CcSEcCtD
Fluvoxamine—Oedema—Temozolomide—skin cancer	0.000175	0.000699	CcSEcCtD
Fluvoxamine—Infection—Temozolomide—skin cancer	0.000174	0.000694	CcSEcCtD
Fluvoxamine—Nausea—Imiquimod—skin cancer	0.000174	0.000692	CcSEcCtD
Fluvoxamine—Hepatobiliary disease—Docetaxel—skin cancer	0.000173	0.000689	CcSEcCtD
Fluvoxamine—Epistaxis—Docetaxel—skin cancer	0.000172	0.000687	CcSEcCtD
Fluvoxamine—Nervous system disorder—Temozolomide—skin cancer	0.000172	0.000685	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Temozolomide—skin cancer	0.000172	0.000684	CcSEcCtD
Fluvoxamine—Convulsion—Fluorouracil—skin cancer	0.000171	0.000683	CcSEcCtD
Fluvoxamine—Feeling abnormal—Bleomycin—skin cancer	0.000171	0.000682	CcSEcCtD
Fluvoxamine—Agranulocytosis—Docetaxel—skin cancer	0.000171	0.00068	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Temozolomide—skin cancer	0.000169	0.000675	CcSEcCtD
Fluvoxamine—Myalgia—Fluorouracil—skin cancer	0.000168	0.000671	CcSEcCtD
Fluvoxamine—Chest pain—Fluorouracil—skin cancer	0.000168	0.000671	CcSEcCtD
Fluvoxamine—Decreased appetite—Dactinomycin—skin cancer	0.000168	0.000671	CcSEcCtD
Fluvoxamine—Fatigue—Dactinomycin—skin cancer	0.000167	0.000666	CcSEcCtD
Fluvoxamine—Anorexia—Temozolomide—skin cancer	0.000167	0.000666	CcSEcCtD
Fluvoxamine—Discomfort—Fluorouracil—skin cancer	0.000166	0.000663	CcSEcCtD
Fluvoxamine—Pain—Dactinomycin—skin cancer	0.000166	0.00066	CcSEcCtD
Fluvoxamine—Urticaria—Bleomycin—skin cancer	0.000165	0.000658	CcSEcCtD
Fluvoxamine—Haemoglobin—Docetaxel—skin cancer	0.000165	0.000657	CcSEcCtD
Fluvoxamine—Rhinitis—Docetaxel—skin cancer	0.000165	0.000656	CcSEcCtD
Fluvoxamine—Body temperature increased—Bleomycin—skin cancer	0.000164	0.000655	CcSEcCtD
Fluvoxamine—Haemorrhage—Docetaxel—skin cancer	0.000164	0.000654	CcSEcCtD
Fluvoxamine—Hepatitis—Docetaxel—skin cancer	0.000164	0.000654	CcSEcCtD
Fluvoxamine—Hypoaesthesia—Docetaxel—skin cancer	0.000163	0.000651	CcSEcCtD
Fluvoxamine—Confusional state—Fluorouracil—skin cancer	0.000163	0.000649	CcSEcCtD
Fluvoxamine—Pharyngitis—Docetaxel—skin cancer	0.000163	0.000649	CcSEcCtD
Fluvoxamine—Urinary tract disorder—Docetaxel—skin cancer	0.000162	0.000646	CcSEcCtD
Fluvoxamine—Oedema peripheral—Docetaxel—skin cancer	0.000162	0.000644	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Fluorouracil—skin cancer	0.000162	0.000644	CcSEcCtD
Fluvoxamine—Oedema—Fluorouracil—skin cancer	0.000162	0.000644	CcSEcCtD
Fluvoxamine—Urethral disorder—Docetaxel—skin cancer	0.000161	0.000641	CcSEcCtD
Fluvoxamine—Infection—Fluorouracil—skin cancer	0.00016	0.000639	CcSEcCtD
Fluvoxamine—Feeling abnormal—Dactinomycin—skin cancer	0.00016	0.000636	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00016	0.000636	CcSEcCtD
Fluvoxamine—Insomnia—Temozolomide—skin cancer	0.000159	0.000632	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Dactinomycin—skin cancer	0.000158	0.000632	CcSEcCtD
Fluvoxamine—Nervous system disorder—Fluorouracil—skin cancer	0.000158	0.000631	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Fluorouracil—skin cancer	0.000158	0.00063	CcSEcCtD
Fluvoxamine—Visual impairment—Docetaxel—skin cancer	0.000158	0.00063	CcSEcCtD
Fluvoxamine—Tachycardia—Fluorouracil—skin cancer	0.000158	0.000628	CcSEcCtD
Fluvoxamine—Paraesthesia—Temozolomide—skin cancer	0.000157	0.000627	CcSEcCtD
Fluvoxamine—Dyspnoea—Temozolomide—skin cancer	0.000156	0.000623	CcSEcCtD
Fluvoxamine—Somnolence—Temozolomide—skin cancer	0.000156	0.000621	CcSEcCtD
Fluvoxamine—Erythema multiforme—Docetaxel—skin cancer	0.000155	0.000618	CcSEcCtD
Fluvoxamine—Dyspepsia—Temozolomide—skin cancer	0.000154	0.000615	CcSEcCtD
Fluvoxamine—Anorexia—Fluorouracil—skin cancer	0.000154	0.000614	CcSEcCtD
Fluvoxamine—Eye disorder—Docetaxel—skin cancer	0.000153	0.000611	CcSEcCtD
Fluvoxamine—Abdominal pain—Dactinomycin—skin cancer	0.000153	0.000611	CcSEcCtD
Fluvoxamine—Body temperature increased—Dactinomycin—skin cancer	0.000153	0.000611	CcSEcCtD
Fluvoxamine—Hypersensitivity—Bleomycin—skin cancer	0.000153	0.00061	CcSEcCtD
Fluvoxamine—Decreased appetite—Temozolomide—skin cancer	0.000152	0.000607	CcSEcCtD
Fluvoxamine—Cardiac disorder—Docetaxel—skin cancer	0.000152	0.000607	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Temozolomide—skin cancer	0.000151	0.000603	CcSEcCtD
Fluvoxamine—Fatigue—Temozolomide—skin cancer	0.000151	0.000602	CcSEcCtD
Fluvoxamine—Hypotension—Fluorouracil—skin cancer	0.000151	0.000601	CcSEcCtD
Fluvoxamine—Pain—Temozolomide—skin cancer	0.00015	0.000597	CcSEcCtD
Fluvoxamine—Constipation—Temozolomide—skin cancer	0.00015	0.000597	CcSEcCtD
Fluvoxamine—Asthenia—Bleomycin—skin cancer	0.000149	0.000594	CcSEcCtD
Fluvoxamine—Angiopathy—Docetaxel—skin cancer	0.000149	0.000593	CcSEcCtD
Fluvoxamine—Chills—Docetaxel—skin cancer	0.000147	0.000587	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000147	0.000586	CcSEcCtD
Fluvoxamine—Pruritus—Bleomycin—skin cancer	0.000147	0.000586	CcSEcCtD
Fluvoxamine—Arrhythmia—Docetaxel—skin cancer	0.000147	0.000584	CcSEcCtD
Fluvoxamine—Insomnia—Fluorouracil—skin cancer	0.000146	0.000582	CcSEcCtD
Fluvoxamine—Paraesthesia—Fluorouracil—skin cancer	0.000145	0.000578	CcSEcCtD
Fluvoxamine—Alopecia—Docetaxel—skin cancer	0.000145	0.000578	CcSEcCtD
Fluvoxamine—Feeling abnormal—Temozolomide—skin cancer	0.000144	0.000576	CcSEcCtD
Fluvoxamine—Dyspnoea—Fluorouracil—skin cancer	0.000144	0.000574	CcSEcCtD
Fluvoxamine—Mental disorder—Docetaxel—skin cancer	0.000144	0.000573	CcSEcCtD
Fluvoxamine—Somnolence—Fluorouracil—skin cancer	0.000144	0.000572	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Temozolomide—skin cancer	0.000143	0.000571	CcSEcCtD
Fluvoxamine—Malnutrition—Docetaxel—skin cancer	0.000143	0.000569	CcSEcCtD
Fluvoxamine—Hypersensitivity—Dactinomycin—skin cancer	0.000143	0.000569	CcSEcCtD
Fluvoxamine—Dyspepsia—Fluorouracil—skin cancer	0.000142	0.000567	CcSEcCtD
Fluvoxamine—Decreased appetite—Fluorouracil—skin cancer	0.00014	0.00056	CcSEcCtD
Fluvoxamine—Dysgeusia—Docetaxel—skin cancer	0.00014	0.000557	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000139	0.000556	CcSEcCtD
Fluvoxamine—Urticaria—Temozolomide—skin cancer	0.000139	0.000555	CcSEcCtD
Fluvoxamine—Asthenia—Dactinomycin—skin cancer	0.000139	0.000554	CcSEcCtD
Fluvoxamine—Abdominal pain—Temozolomide—skin cancer	0.000139	0.000552	CcSEcCtD
Fluvoxamine—Body temperature increased—Temozolomide—skin cancer	0.000139	0.000552	CcSEcCtD
Fluvoxamine—Back pain—Docetaxel—skin cancer	0.000138	0.000551	CcSEcCtD
Fluvoxamine—Pain—Fluorouracil—skin cancer	0.000138	0.00055	CcSEcCtD
Fluvoxamine—Muscle spasms—Docetaxel—skin cancer	0.000137	0.000547	CcSEcCtD
Fluvoxamine—Feeling abnormal—Fluorouracil—skin cancer	0.000133	0.00053	CcSEcCtD
Fluvoxamine—Diarrhoea—Dactinomycin—skin cancer	0.000133	0.000528	CcSEcCtD
Fluvoxamine—Vomiting—Bleomycin—skin cancer	0.000132	0.000527	CcSEcCtD
Fluvoxamine—Anaemia—Docetaxel—skin cancer	0.000132	0.000526	CcSEcCtD
Fluvoxamine—Rash—Bleomycin—skin cancer	0.000131	0.000522	CcSEcCtD
Fluvoxamine—Dermatitis—Bleomycin—skin cancer	0.000131	0.000522	CcSEcCtD
Fluvoxamine—Hypersensitivity—Temozolomide—skin cancer	0.000129	0.000515	CcSEcCtD
Fluvoxamine—Urticaria—Fluorouracil—skin cancer	0.000128	0.000511	CcSEcCtD
Fluvoxamine—Syncope—Docetaxel—skin cancer	0.000128	0.00051	CcSEcCtD
Fluvoxamine—Leukopenia—Docetaxel—skin cancer	0.000128	0.00051	CcSEcCtD
Fluvoxamine—Body temperature increased—Fluorouracil—skin cancer	0.000128	0.000509	CcSEcCtD
Fluvoxamine—Palpitations—Docetaxel—skin cancer	0.000126	0.000503	CcSEcCtD
Fluvoxamine—Asthenia—Temozolomide—skin cancer	0.000126	0.000501	CcSEcCtD
Fluvoxamine—Loss of consciousness—Docetaxel—skin cancer	0.000126	0.0005	CcSEcCtD
Fluvoxamine—Cough—Docetaxel—skin cancer	0.000125	0.000497	CcSEcCtD
Fluvoxamine—Pruritus—Temozolomide—skin cancer	0.000124	0.000494	CcSEcCtD
Fluvoxamine—Convulsion—Docetaxel—skin cancer	0.000124	0.000493	CcSEcCtD
Fluvoxamine—Nausea—Bleomycin—skin cancer	0.000123	0.000492	CcSEcCtD
Fluvoxamine—Hypertension—Docetaxel—skin cancer	0.000123	0.000491	CcSEcCtD
Fluvoxamine—Vomiting—Dactinomycin—skin cancer	0.000123	0.000491	CcSEcCtD
Fluvoxamine—Rash—Dactinomycin—skin cancer	0.000122	0.000487	CcSEcCtD
Fluvoxamine—Arthralgia—Docetaxel—skin cancer	0.000122	0.000485	CcSEcCtD
Fluvoxamine—Chest pain—Docetaxel—skin cancer	0.000122	0.000485	CcSEcCtD
Fluvoxamine—Myalgia—Docetaxel—skin cancer	0.000122	0.000485	CcSEcCtD
Fluvoxamine—Diarrhoea—Temozolomide—skin cancer	0.00012	0.000478	CcSEcCtD
Fluvoxamine—Hypersensitivity—Fluorouracil—skin cancer	0.000119	0.000474	CcSEcCtD
Fluvoxamine—Dry mouth—Docetaxel—skin cancer	0.000119	0.000474	CcSEcCtD
Fluvoxamine—Confusional state—Docetaxel—skin cancer	0.000118	0.000468	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Docetaxel—skin cancer	0.000117	0.000465	CcSEcCtD
Fluvoxamine—Oedema—Docetaxel—skin cancer	0.000117	0.000465	CcSEcCtD
Fluvoxamine—Dizziness—Temozolomide—skin cancer	0.000116	0.000462	CcSEcCtD
Fluvoxamine—Infection—Docetaxel—skin cancer	0.000116	0.000462	CcSEcCtD
Fluvoxamine—Nausea—Dactinomycin—skin cancer	0.000115	0.000459	CcSEcCtD
Fluvoxamine—Shock—Docetaxel—skin cancer	0.000115	0.000457	CcSEcCtD
Fluvoxamine—Nervous system disorder—Docetaxel—skin cancer	0.000114	0.000456	CcSEcCtD
Fluvoxamine—Pruritus—Fluorouracil—skin cancer	0.000114	0.000455	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Docetaxel—skin cancer	0.000114	0.000455	CcSEcCtD
Fluvoxamine—Tachycardia—Docetaxel—skin cancer	0.000114	0.000453	CcSEcCtD
Fluvoxamine—Vomiting—Temozolomide—skin cancer	0.000111	0.000444	CcSEcCtD
Fluvoxamine—Anorexia—Docetaxel—skin cancer	0.000111	0.000443	CcSEcCtD
Fluvoxamine—Rash—Temozolomide—skin cancer	0.000111	0.00044	CcSEcCtD
Fluvoxamine—Diarrhoea—Fluorouracil—skin cancer	0.000111	0.00044	CcSEcCtD
Fluvoxamine—Dermatitis—Temozolomide—skin cancer	0.00011	0.00044	CcSEcCtD
Fluvoxamine—Headache—Temozolomide—skin cancer	0.00011	0.000438	CcSEcCtD
Fluvoxamine—Hypotension—Docetaxel—skin cancer	0.000109	0.000434	CcSEcCtD
Fluvoxamine—Dizziness—Fluorouracil—skin cancer	0.000107	0.000426	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000106	0.000423	CcSEcCtD
Fluvoxamine—Insomnia—Docetaxel—skin cancer	0.000105	0.00042	CcSEcCtD
Fluvoxamine—Paraesthesia—Docetaxel—skin cancer	0.000105	0.000417	CcSEcCtD
Fluvoxamine—Nausea—Temozolomide—skin cancer	0.000104	0.000415	CcSEcCtD
Fluvoxamine—Dyspnoea—Docetaxel—skin cancer	0.000104	0.000414	CcSEcCtD
Fluvoxamine—Somnolence—Docetaxel—skin cancer	0.000104	0.000413	CcSEcCtD
Fluvoxamine—Vomiting—Fluorouracil—skin cancer	0.000103	0.000409	CcSEcCtD
Fluvoxamine—Dyspepsia—Docetaxel—skin cancer	0.000103	0.000409	CcSEcCtD
Fluvoxamine—Rash—Fluorouracil—skin cancer	0.000102	0.000406	CcSEcCtD
Fluvoxamine—Dermatitis—Fluorouracil—skin cancer	0.000102	0.000405	CcSEcCtD
Fluvoxamine—Decreased appetite—Docetaxel—skin cancer	0.000101	0.000404	CcSEcCtD
Fluvoxamine—Headache—Fluorouracil—skin cancer	0.000101	0.000403	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Docetaxel—skin cancer	0.000101	0.000401	CcSEcCtD
Fluvoxamine—Fatigue—Docetaxel—skin cancer	0.000101	0.000401	CcSEcCtD
Fluvoxamine—Pain—Docetaxel—skin cancer	9.97e-05	0.000397	CcSEcCtD
Fluvoxamine—Constipation—Docetaxel—skin cancer	9.97e-05	0.000397	CcSEcCtD
Fluvoxamine—Feeling abnormal—Docetaxel—skin cancer	9.61e-05	0.000383	CcSEcCtD
Fluvoxamine—Nausea—Fluorouracil—skin cancer	9.59e-05	0.000382	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Docetaxel—skin cancer	9.53e-05	0.00038	CcSEcCtD
Fluvoxamine—Abdominal pain—Docetaxel—skin cancer	9.22e-05	0.000367	CcSEcCtD
Fluvoxamine—Body temperature increased—Docetaxel—skin cancer	9.22e-05	0.000367	CcSEcCtD
Fluvoxamine—Hypersensitivity—Docetaxel—skin cancer	8.59e-05	0.000342	CcSEcCtD
Fluvoxamine—Asthenia—Docetaxel—skin cancer	8.36e-05	0.000333	CcSEcCtD
Fluvoxamine—Pruritus—Docetaxel—skin cancer	8.25e-05	0.000329	CcSEcCtD
Fluvoxamine—Diarrhoea—Docetaxel—skin cancer	7.98e-05	0.000318	CcSEcCtD
Fluvoxamine—Dizziness—Docetaxel—skin cancer	7.71e-05	0.000307	CcSEcCtD
Fluvoxamine—Vomiting—Docetaxel—skin cancer	7.41e-05	0.000295	CcSEcCtD
Fluvoxamine—Rash—Docetaxel—skin cancer	7.35e-05	0.000293	CcSEcCtD
Fluvoxamine—Dermatitis—Docetaxel—skin cancer	7.34e-05	0.000293	CcSEcCtD
Fluvoxamine—Headache—Docetaxel—skin cancer	7.3e-05	0.000291	CcSEcCtD
Fluvoxamine—Nausea—Docetaxel—skin cancer	6.92e-05	0.000276	CcSEcCtD
